|
Gal-1 directly binds to the envelope glycoproteins of influenza virus and constrain the viral hemagglutination activity and infectivity. |
A/WSN/1933(H1N1) |
[28] |
Galectin-1
|
Recombinant Gal-1 (rGal-1) treatment reduced mice fatality via mediating the expression of cytokines and chemokines. |
2009 influenza A H1N1 subtype (H1N1pdm09) |
[25] |
Gal-1 participated in regulation of cytopathic processes by H1N1pdm09 virus to induce an arrest of the cell cycle at the G0/G1 phase. |
H1N1pdm09 |
[30] |
Gal-1 expression was correlated with the differential susceptibility to H7N9 influenza via extracellular matrix (ECM)-receptor interaction and mitogen-activated protein kinase (MAPK) signaling. |
Human H7N9 isolates |
[31] |
IAVs and S. pneumoniae coinfection induced the secretion of Gal-1 to the epithelial cell surface and further modulated the expression of SOCS1 and RIG1 and activate ERK, AKT, or JAK/STAT1 signaling pathways. |
H1N1pdm09 |
[42] |
Galectin-3
|
Aloe-emodin treatment ameliorated influenza H1N1 virus infection via up-regulation of Gal-3 expression to further trigger antiviral genes expression |
A/Taiwan/CMUH01/2007(H1N1) |
[38] |
Gal-3 enhances effects of H5N1 promoting host inflammatory response by up-regulating IL-1β via NLRP3. |
A/Vietnam/1204/03 |
[41] |
IAVs and S. pneumoniae coinfection induced the secretion of Gal-3 to the epithelial cell surface and further modulated the expression of SOCS1 and RIG1, and activate ERK, AKT, or JAK/STAT1 signaling pathways. |
H1N1pdm09 |
[42] |
Gal-3 preferred binding to desialylated multivalent glycoligands. |
A/PuertoRico/08/1934 (H1N1) |
[43] |
Galectin-9
|
Gal-9 inhibited the infection of IAVs via Gal-9 binding to influenza virus particles to inhibit virus attachment. |
A/Puerto Rico/8/34 (H1N1); Aichi/2/68 (H3N2); A/Hong Kong/483/97 (H5N1) |
[51] |
Virus-specific CD8 T cells upregulate Tim-3 expression and Gal-9/Tim-3 interaction induce cell apoptosis after IAV infection from in vitro and ex vivo assays. |
HK/×31 (H3N2) A/Puerto Rico/8/34 (H1N1)) |
[55] |
Influenza virus infection induces plasma Gal-9 expression, suggesting Gal-9 as a possible biomarker for influenza. |
Seasonal influenza virus |
[56] |